We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

An Analytical Method to Monitor Dietary Fat Intake

By LabMedica International staff writers
Posted on 25 May 2020
Print article
Image: A multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometer (MSI-NACE-MS) (Photo courtesy of McMaster University)
Image: A multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometer (MSI-NACE-MS) (Photo courtesy of McMaster University)
An advanced analytical technique was used to determine unequivocally the composition of fats in the diets of pregnant women and female patients suspected of being deficient in certain dietary fats.

Investigators at McMaster University (Hamilton, Ontario, Canada) sought to develop a method to monitor objectively dietary fat intake in women that would be complementary to the currently used self-kept dietary records or food frequency questionnaires. For this purpose, they turned to the advanced analytical technique known as multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometry or MSI-NACE-MS.

Capillary electrophoresis-mass spectrometry (CE-MS), is a high efficiency microseparation platform that is ideal for analysis of a broad range of ionic metabolites in volume-restricted or mass-limited biological specimens. Selectivity in CE is based on differences in the electrophoretic mobility of metabolites in aqueous or non-aqueous buffer conditions that can be predicted accurately based on their physicochemical properties, which is coupled to an electrospray ionization (ESI) source prior to high resolution, accurate mass analysis.

The method includes sequential injection of multiple sample segments in series within a single capillary, the sample segments being separated by a spacer plug of buffer, and multiplexed analysis of the sample segments simultaneously within a single capillary electrophoresis run. Classes of metabolites optimal to CE-MS include amino acids, biogenic amines, organic acids, nucleotides, sugar phosphates, acylcarnitines, acylglycines, fatty acids, and various drugs/exogenous compounds that often require minimal sample pretreatment while using small volumes (five to 20 microliters) of biological samples (e.g., urine, plasma, sweat, tissue biopsies), including dried blood spots cut-out on filter paper.

For the current study, the investigators used MSI-NACE-MS to investigate whether specific serum non-esterified fatty acids (NEFA) would have utility as biomarkers of dietary fat intake in women. Initially, they identified circulating NEFAs that correlated with long-term/habitual food intake among 50 pregnant women with contrasting dietary patterns. Acute changes in serum NEFA trajectories were also studied in 18 non-pregnant women following high-dose (five grams/day) fish oil supplementation or sunflower oil placebo over 56 days.

Results from the cohort of pregnant women revealed that serum omega-3 fatty acid correlated with self-reported total omega-3 daily intake, notably eicosapentaenoic acid (EPA) as its NEFA, whereas pentadecanoic acid was associated with full-fat dairy intake. These outcomes were consistent with results from total fatty acid serum hydrolysates.

In the intervention cohort, serum omega-3 NEFAs increased 2.5-fold from baseline within 28 days following fish oil supplementation, and this increase was most pronounced for EPA. Unlike for docosahexaenoic acid, circulating EPA, as its NEFA, also strongly correlated to EPA concentrations measured from erythrocyte phospholipid hydrolysates and was better suited to detect dietary non-adherence.

"The food we consume is highly complex and difficult to measure when relying on self-reporting or memory recall, particularly in the case of dietary fats. There are thousands of chemicals that we are exposed to in foods, both processed and natural. Epidemiologists need better ways to reliably assess dietary intake when developing nutritional recommendations," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "Fat intake is among the most controversial aspects of nutritional public health policies given previously flawed low-fat diet recommendations, and the growing popularity of low-carb/high-fat ketogenic based diets. If we can measure it reliably, we can begin to study such questions as: Should pregnant women take fish oil? Are women deficient in certain dietary fats? Does a certain diet or supplement lead to better health outcomes for their babies?"

The dietary fat study was published in the March 31, 2020, online edition of the Journal of Lipid Research.

Related Links:
McMaster University

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
Silver Member
ACTH Assay
ACTH ELISA

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.